Related Experiment Video
Updated: Jul 9, 2026
Megakaryocyte Culture in 3D Methylcellulose-Based Hydrogel to Improve Cell Maturation and Study the Impact of Stiffness and Confinement
Published on: August 26, 2021
Calyculin A retraction of mature megakaryocytes proplatelets from embryonic stem cells
Satoshi Tamaru1, Kenji Kitajima, Tohru Nakano
1Institute of Human Research Promotion and Drug Development, Mie University, Faculty of Medicine, Mie 514-8507, Japan.
Abstract:
Platelets are produced by megakaryocytes (MKs) through proplatelet formation (PPF), or cytoplasmic extensions, in vitro. Through the use of video-enhanced light microscopy, as well as localization of cytoskeletal proteins by confocal microscopy, the reaction of fully mature MK proplatelets, derived from murine embryonic stem cells, to various agents was studied. Calyculin A (protein phosphatase 1/2A inhibitor) treatment induced proplatelet retraction. In MKs with PPF, the expression of actin, myosin IIA, monophosphorylated myosin light chain (MLC-P1), and diphosphorylated myosin light chain (MLC-P2) was diffusely located. Following calyculin A treatment, actin was diffusely localized in retracted MKs and was expressed particularly in the periphery. MLC-P1 was also localized primarily in the periphery; however, MLC-P2 was expressed mostly in the inner area of proplatelets. Protein phosphatase inhibitors may result in increased hyperphosphorylation of localized MLC, which could alter the balance of actomyosin force in a cell, and therefore induce proplatelets retraction.
Insights
Protein phosphatase inhibitors like calyculin A cause megakaryocyte proplatelet retraction. This retraction is linked to altered myosin light chain phosphorylation and actomyosin force balance during platelet formation.
Area of Science:
- Hematology
- Cell Biology
- Biochemistry
Background:
- Platelets are essential blood components crucial for hemostasis.
- Megakaryocytes (MKs) generate platelets via proplatelet formation (PPF).
- The cytoskeletal dynamics governing PPF are not fully understood.
Purpose of the Study:
- To investigate the effects of protein phosphatase inhibitors on MK proplatelet structure.
- To elucidate the role of cytoskeletal proteins, particularly myosin IIA, in PPF regulation.
- To understand the mechanism of proplatelet retraction induced by specific agents.
Main Methods:
- Utilized video-enhanced light microscopy to observe live MKs and proplatelets.
- Employed confocal microscopy for cytoskeletal protein localization (actin, myosin IIA, MLC-P1, MLC-P2).
- Studied proplatelets derived from murine embryonic stem cells treated with calyculin A.
Main Results:
- Calyculin A, a protein phosphatase 1/2A inhibitor, induced significant proplatelet retraction.
- In untreated MKs, actin and myosin IIA components were diffusely distributed.
- Post-calyculin A treatment, actin and monophosphorylated myosin light chain (MLC-P1) localized to the periphery, while diphosphorylated myosin light chain (MLC-P2) concentrated centrally.
Conclusions:
- Protein phosphatase inhibition disrupts the normal cytoskeletal organization during PPF.
- Altered myosin light chain phosphorylation patterns suggest a role in regulating actomyosin contractility.
- These changes in actomyosin force balance likely mediate proplatelet retraction.
